Amlodipin



Indications and Reactions:

Role Indications Reactions
Primary
Essential Hypertension 25.0%
Atrial Fibrillation 12.5%
Benign Prostatic Hyperplasia 12.5%
Gastrooesophageal Reflux Disease 12.5%
Hypercholesterolaemia 12.5%
Iron Deficiency 12.5%
Type 2 Diabetes Mellitus 12.5%
Vomiting 33.3%
Pemphigus 16.7%
Pleural Effusion 16.7%
Shock 16.7%
Weight Decreased 16.7%
Secondary
Product Used For Unknown Indication 23.7%
Hypertension 14.4%
Essential Hypertension 7.2%
Type 2 Diabetes Mellitus 7.2%
Hypercholesterolaemia 4.1%
Rheumatoid Arthritis 4.1%
Thrombosis Prophylaxis 4.1%
Hypertension 3.1%
Benign Prostatic Hyperplasia 3.1%
Gastroenteritis 3.1%
Gastrooesophageal Reflux Disease 3.1%
Her-2 Positive Breast Cancer 3.1%
Iron Deficiency 3.1%
Mineral Supplementation 3.1%
Optic Nerve Disorder 3.1%
Anaemia 2.1%
Bladder Disorder 2.1%
Clostridial Infection 2.1%
Eye Disorder 2.1%
Hepatitis C 2.1%
Vomiting 13.8%
Pemphigus 10.3%
Hypotension 6.9%
Overdose 6.9%
Syncope 6.9%
Tubulointerstitial Nephritis 6.9%
Accidental Overdose 3.4%
Drug Abuse 3.4%
Gamma-glutamyltransferase Increased 3.4%
Infarction 3.4%
Leukopenia 3.4%
Nausea 3.4%
Nervous System Disorder 3.4%
Pruritus 3.4%
Sleep Apnoea Syndrome 3.4%
Somnolence 3.4%
Throat Irritation 3.4%
Tonsillitis 3.4%
Toxic Epidermal Necrolysis 3.4%
Weight Fluctuation 3.4%
Concomitant
Product Used For Unknown Indication 33.1%
Hypertension 23.7%
Rheumatoid Arthritis 10.2%
Pain 3.7%
Prophylaxis 3.3%
Parkinson's Disease 2.8%
Diabetes Mellitus 2.5%
Atrial Fibrillation 2.5%
Chronic Obstructive Pulmonary Disease 2.3%
Breast Cancer 2.2%
Type 2 Diabetes Mellitus 2.1%
Coronary Artery Disease 1.6%
Osteoporosis 1.6%
B-cell Lymphoma 1.3%
Gastrooesophageal Reflux Disease 1.3%
Thrombosis Prophylaxis 1.3%
Hypercholesterolaemia 1.2%
Psoriasis 1.1%
Colon Cancer 1.1%
Hyperparathyroidism Secondary 1.1%
Vomiting 11.7%
Renal Failure Acute 10.8%
Weight Decreased 9.2%
Wrong Technique In Drug Usage Process 7.5%
Carotid Artery Stenosis 5.0%
Pulmonary Embolism 5.0%
Renal Failure 4.2%
Sepsis 4.2%
Syncope 4.2%
Tachycardia 4.2%
Urinary Tract Infection 4.2%
Death 3.3%
Drug Ineffective 3.3%
Dyspnoea 3.3%
Hypertension 3.3%
Nausea 3.3%
Pneumonia 3.3%
Respiratory Failure 3.3%
Systemic Lupus Erythematosus 3.3%
Visual Impairment 3.3%